NCT04204863 Status Epilepticus Population Study (STEPS)
| NCT ID | NCT04204863 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Epileptic Seizures |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-04-19 |
| Primary Completion | 2050-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-04-19 with a primary completion date of 2050-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).
Eligibility Criteria
Inclusion Criteria: * Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2023 who have been treated at the University Hospital of Basel or the Cantonal Hospital Aarau. Exclusion Criteria: * Patients younger than 18 years. * Patients with repetitive epileptic seizures not qualifying for SE. * Patients with documented refusal of the general consent.
Contact & Investigator
Raoul Sutter, PD Dr. med
PRINCIPAL INVESTIGATOR
Clinic for Intensive Care Medicine, University Hospital Basel
Frequently Asked Questions
Who can join the NCT04204863 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Epileptic Seizures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04204863 currently recruiting?
Yes, NCT04204863 is actively recruiting participants. Contact the research team at Raoul.Sutter@usb.ch for enrollment information.
Where is the NCT04204863 trial being conducted?
This trial is being conducted at Aarau, Switzerland, Basel, Switzerland.
Who is sponsoring the NCT04204863 clinical trial?
NCT04204863 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Raoul Sutter, PD Dr. med at Clinic for Intensive Care Medicine, University Hospital Basel. The trial plans to enroll 1,000 participants.